EQUINOX NEPREMICNINE d.d. Revenue

EQUINOX NEPREMICNINE d.d. had revenue of 2.67M EUR in the quarter ending September 30, 2024, with 63.06% growth. This brings the company's revenue in the last twelve months to 8.50M, up 11.99% year-over-year. In the year 2023, EQUINOX NEPREMICNINE d.d. had annual revenue of 7.79M with 6.03% growth.

Revenue (ttm)

8.50M

Revenue Growth

+11.99%

P/S Ratio

12.42

Revenue / Employee

n/a

Employees

n/a

Market Cap

105.54M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	7.79M	442.80K	6.03%
Dec 31, 2022	7.34M	629.52K	9.38%
Dec 31, 2021	6.71M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition